Ladislas Lozano

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Essex Property Trust reports strong Q3 earnings, but its stock declines amid mixed market performance.
  • Red Sox sign veteran catcher Jason Delay to minor-league deal, adding depth as Carlos Narvaez and Connor Wong recover from surgeries.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Essex Property Trust reports strong Q3 earnings, but its stock declines amid mixed market performance.
  • Red Sox sign veteran catcher Jason Delay to minor-league deal, adding depth as Carlos Narvaez and Connor Wong recover from surgeries.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Ladislas Lozano